Aeon BiopharmaAEON
13F holders, Q1 2025 (March 31)16holders
$0.58avg. 13F price*
At the end of Q1 2025, 16 institutions reported holding Aeon Biopharma Inc. (AEON) in their 13F filings. The largest holders were Dauntless Investment Group, LLC ($594K), Sabby Management, LLC ($261K) and Blue Owl Capital Holdings LP ($25K).
- Company
- Aeon Biopharma Inc.
- CUSIP
- 00791X209
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $855K |
| Exits | 0 | $0 |
Ownership 16 holders
| Dauntless Investment Group, LLC | 2.19% | New | 1,025,000 | $594K |
| Sabby Management, LLC | 1.09% | New | 449,687 | $261K |
| Blue Owl Capital Holdings LP | 0.01% | Add +0.3% | 42,353 | $25K |
| BlackRock, Inc. | 0.00% | Reduce -0.1% | 3,671 | $2K |
| UBS Group AG | 0.00% | Add +337.8% | 2,957 | $2K |
| Bank of America Corp. | 0.00% | Add +0.6% | 2,319 | $1K |
| Dupont Capital Management Corp. | 0.00% | No change | 170 | $99 |
| Morgan Stanley | 0.00% | Reduce -0.3% | 150 | $87 |
| SBI Securities Co., Ltd. | 0.00% | Add +7335.1% | 106 | $61 |
| Steward Partners Investment Advisory, LLC | 0.00% | Reduce -11.9% | 100 | $58 |
| Wells Fargo & Company | 0.00% | No change | 90 | $52 |
| Wolff Wiese Magana LLC | 0.00% | Add +0.1% | 67 | $39 |
| MAI Capital Management | 0.00% | Reduce -1.2% | 58 | $34 |
| CIBC Private Wealth Group LLC | 0.00% | Reduce -1.4% | 33 | $14 |
| GHP Investment Advisors, Inc. | 0.00% | Reduce -1.0% | 15 | $9 |
| Danske Bank A/S | 0.00% | New | 1 | $1 |
"% of holder's portfolio" is AEON's weight in each manager's 13F, not the share of Aeon Biopharma Inc. the manager owns.